Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
Clover Health Investments, Corp. - Class A Common stock (CLOV)
Company Research
Source: GlobeNewswire
SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV), today released key 2025 highlights. The past year was defined by continued publication of research demonstrating the platform's impact on chronic disease management, meaningful product expansion, and the scaled adoption of Counterpart Assistant (CA) by hundreds of live third-party customer clinicians across diverse practice settings. Clinical Quality and Financial Performance Outcomes Data released in 2025 highlights the scale and consistency of the platform's impact. These outcomes reflect the cumulative effect of thousands of better clinical decisions made during real patient visits: Clinician Adoption: Counterpart recorded a 450% Year-over-Year increase in live third-party customer clinicians, now representing hundreds of third-party customer clinicians l
Show less
Read more
Impact Snapshot
Event Time:
CLOV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLOV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLOV alerts
High impacting Clover Health Investments, Corp. - Class A Common stock news events
Weekly update
A roundup of the hottest topics
CLOV
News
- Clover Health Investments, Corp. (CLOV): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- IRHYTHM HLDGS (IRTC) Moves 5.0% Higher: Will This Strength Last? [Yahoo! Finance]Yahoo! Finance
- A Look At Clover Health (CLOV) Valuation After Membership Surge And First Profit Outlook [Yahoo! Finance]Yahoo! Finance
- Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026GlobeNewswire
- Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost [Yahoo! Finance]Yahoo! Finance
CLOV
Earnings
- 11/4/25 - In-Line
CLOV
Analyst Actions
- 11/6/25 - Canaccord Genuity
CLOV
Sec Filings
- 1/14/26 - Form 8-K
- 1/9/26 - Form 4
- 1/8/26 - Form 4
- CLOV's page on the SEC website